Announcement on Convening the Q3 2025 Performance Briefing

About this update from Kexing Biopharm Co., Ltd. Class A

Announcement on Convening the Q3 2025 Performance BriefingThe abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Kexing Biopharm Co., Ltd. Class A